We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Polymer Film Packed with Antibodies Used to Capture Tumor Cells

By LabMedica International staff writers
Posted on 15 Mar 2012
The development of polymer film packed with antibodies that can grab tumor cells demonstrates potential as an effective diagnostic tool. More...


Metastasis, the process when cancer cells that break free from a tumor and circulate through the bloodstream spread cancer to other parts of the body, is extremely difficult to monitor because the circulating tumor cells (CTCs) can account for as few as one in every billion blood cells.

Research led by scientists from the RIKEN Advanced Science Institute (Wako, Japan), in collaboration with colleagues at the University of California, Los Angeles (UCLA; USA) and the Institute of Chemistry at the Chinese Academy of Sciences (Beijing, China), has created a polymer film that can capture specific CTCs. With additional modifications, the system could help clinicians to identify an advancing cancer and assess the effectiveness of treatments.

The researchers utilized a small electrical voltage to help deposit a conducting polymer film of poly(3,4-ethylenedioxythiophene) (PEDOT) bearing carboxylic acid groups on to a 2-cm2 glass base. The polymer formed nanodots, minuscule bumps that measure 100-300 nm across, depending on the voltage used (1-1.4 V).

Adding a chemical linker to the film allowed it to bind a protein called streptavidin; this protein then joined to an antibody. After that, the antibody could latch on to an antigen called epithelial cell adhesion molecule (EpCAM), which is generated by most tumor cells. In this manner, the film could capture tumor cells from only a couple of milliliters of a blood sample.

The scientists evaluated several types of tumor cells on films with various sizes and densities of nanodots, and used a microscope to observe how well they captured the cells. The most effective film, with nanodots measuring about 230 nm across and containing about 8 dots per square micrometer, captured approximately 240 breast-cancer cells per mm2 of film. In contrast, it captured fewer than 30 cervical cancer cells that do not express EpCAM, proving that the antibody used on the film is highly selective. A smooth PEDOT-carboxylic acid film with the same antibody captured only about 50 breast cancer cells.

The film’s effectiveness depends on the size and spacing of the nanodots, and the presence of the capturing antibody. Because these can be easily modified, the same application could be used to produce films that sense other types of cells.

The next phase of the research is to “further optimize the nanostructures of the conducting polymers and understand in more detail the cell-capturing mechanism,” said RIKEN unit leader Hsiao-hua Yu. “We are also currently working on a direct electrical readout of the captured cells, without needing to use a microscope.”

The study’s findings were published November 2, 2012, in the journal Advanced Materials.

Related Links:

RIKEN Advanced Science Institute
University of California, Los Angeles
Institute of Chemistry at the Chinese Academy of Sciences



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Genai-based pathological assessment workflow for lung adenocarcinoma (Shen J. et al., Int J Surg 111(7): 4252–4262; 2025)

Generative AI Demonstrates Expert-Level Pathological Assessment of Lung Cancer

Lung adenocarcinoma is one of the most difficult cancers to diagnose accurately, requiring pathologists to spend extensive time examining tissue samples under microscopes to determine tumor grades and... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.